Fundraise

Paediatric health brand Primerry raises $760,000 pre-seed round

What's the deal? PrimerryDealroom has a profile for this one. Try Dealroom →, a paediatric healthcare startup, has raised US$964.2K in a pre-seed round. Founded by Rushabh Nandu and Dr. Nihar Parekh, the Mumbai company builds everyday health products for children aged 2 to 14.

Who's backing it? The round drew Ashish KacholiaDealroom has a profile for this one. Try Dealroom → and Lashit SanghviDealroom has a profile for this one. Try Dealroom →, alongside angel investors Mohit SadaaniDealroom has a profile for this one. Try Dealroom →, Hitesh DhingraDealroom has a profile for this one. Try Dealroom →, Ajay Mehra, and Samir Palod, plus select family offices.

What's the endgame? Primerry wants to replace what it calls legacy, one-size-fits-all formulations with clean products that prioritise taste, ease of use, and clinical credibility. The funds will go toward research and development, hiring a founding team, and expanding distribution across India.

The product: Primerry will launch eight SKUs priced between US$6.78 and US$20.4, sold first through its own direct-to-consumer platform, with a quick-commerce rollout planned within a year. It has also introduced PocDoc, a customisable carry case for children's health essentials, and plans offline sales via pharmacies, paediatric clinics, and speciality stores in Tier-1 cities and metros.

Why now? Co-founder Dr. Parekh says pediatric practice revealed "a clear gap in how everyday health needs, such as growth, immunity, gut health, and coughs and colds are managed." The pitch: build formulations that "rebuild parents' trust" and that "kids should actually enjoy."

The signal: India's paediatric healthcare market remains underserved by modern, parent-first brands. Primerry is betting that informed parents will pay for clean, child-friendly products — and early backers are betting the category is large enough to support a challenger.

Read more: newspatrolling.com

Image credit: Generated with Gemini

More top stories